Log in to save to my catalogue

Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer

Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_86d51004d76d4561833b0a1a56a77b13

Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer

About this item

Full title

Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer

Publisher

Los Angeles, CA: SAGE Publications

Journal title

Cancer Control, 2023, Vol.30, p.10732748231159706-10732748231159706

Language

English

Formats

Publication information

Publisher

Los Angeles, CA: SAGE Publications

More information

Scope and Contents

Contents

Among the three primary gynecological malignancies, ovarian cancer has the lowest incidence but the worst prognosis. Because of the poor prognosis of ovarian cancer patients treated with existing treatments, immunotherapy is emerging as a potentially ideal alternative to surgery, chemotherapy, and targeted therapy. Among immunotherapies, immune che...

Alternative Titles

Full title

Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_86d51004d76d4561833b0a1a56a77b13

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_86d51004d76d4561833b0a1a56a77b13

Other Identifiers

ISSN

1073-2748

E-ISSN

1526-2359

DOI

10.1177/10732748231159706

How to access this item